Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for AlertsDetails
Title
Grant Type
Focus Area
Country
Application Due Date
Optimal management of patients with prostate cancer receiving androgen deprivation therapy (ADT)
Release Date:
Partner: Sumitomo Pharma
Review Process: Pfizer Internal
Education Oncology USA
Improving the Outpatient Management of Emergency Department Patients with Venous Thromboembolism (VTE)
Release Date:
Partner: American College of Emergency Physicians (ACEP)
Review Process: Expert Review Panel
Quality Improvement Internal Medicine USA
Title
Grant Type
Focus Area
Country
Application Due Date
Establishing Concordance in Vaccination
Release Date:
Review Process: Pfizer Internal
Education Vaccines Japan
Promoting Cognition of the Significance of Vaccination and Advancement in Accessibility
Release Date:
Review Process: Pfizer Internal
Education Vaccines Japan
Promoting Understanding and Improving Practices Related to Post-COVID-19 Symptoms
Release Date:
Review Process: Pfizer Internal
Education Hospital Japan
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Latin America
Release Date:
Review Process: Pfizer Internal
Research Rare Disease All
Optimizing Maternal Immunization Practice in Canada
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Quality Improvement Vaccines Canada
Patient Preferences for Drug Delivery: Literature Review
Release Date:
Review Process: Expert Review Panel
Research Support for the Professions All
Global Awards for Research in DMD-AWARD
Release Date:
Review Process: Expert Review Panel
Research Rare Disease All
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Canada
Release Date:
Review Process: Pfizer Internal
Translation: French (link)
Research Rare Disease Canada
Relapsed/Refractory Multiple Myeloma
Release Date:
Review Process: Pfizer Internal
Education Oncology Argentina, Brazil, India, Saudi Arabia, Singapore, Taiwan, Turkey
Invasive Fungal Infections (Global excluding US)
Release Date:
Review Process: Pfizer Internal
Education Hospital All
Early Identification and Diagnosis of Non-Alcoholic Steatohepatitis (NASH) in At-Risk Populations
Release Date:
Review Process: Pfizer Internal
Education Internal Medicine All
Advances in Migraine Therapy
Release Date:
Review Process: Pfizer Internal
Education Internal Medicine USA